feed,title,long_url,short_url
Benzinga,"Cyclacel Presents Phase 1 Clinical Data Showing Safety, Anti-Tumor Activity and Good Oral Bioavailability of Fadraciclib in Patients With Advanced Solid Tumors at the EORTC-NCI-AACR Symposium 2020",https://www.benzinga.com/pressreleases/20/10/g18053277/cyclacel-presents-phase-1-clinical-data-showing-safety-anti-tumor-activity-and-good-oral-bioavaila,https://j.mp/35DCj8q
